CRISPR-Cas guides the future of genetic engineering
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
The diversity, modularity, and efficacy of CRISPR-Cas systems are driving a biotechnological revolution. RNA-guided Cas enzymes have been adopted as tools to manipulate the genomes of cultured cells, animals, and plants, accelerating the pace of fundamental research and enabling clinical and agricultural breakthroughs. We describe the basic mechanisms that set the CRISPR-Cas toolkit apart from other programmable gene-editing technologies, highlighting the diverse and naturally evolved systems now functionalized as biotechnologies. We discuss the rapidly evolving landscape of CRISPR-Cas applications, from gene editing to transcriptional regulation, imaging, and diagnostics. Continuing functional dissection and an expanding landscape of applications position CRISPR-Cas tools at the cutting edge of nucleic acid manipulation that is rewriting biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR-Cas9 and related enzymes have been used to manipulate the genomes of cultured cells, animals and plants, vastly accelerating the pace of fundamental research and enabling breakthroughs in agriculture and synthetic biology (reviewed in refs. 6-9).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Chen, J. S., Ma, E., Harrington, L. B., Da Costa, M., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aar6245 · Cited by 4,507
Self-citationProgrammable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
Nucleic acid detection with CRISPR-Cas13a/C2c2
Gootenberg, J. S., Abudayyeh, O. O., Lee, J. W., Essletzbichler, P., Dy, A. J., Joung, J., Verdine, V., Donghia, N., Daringer, N. M., Freije, C. A., et al. (2017) · Science · doi:10.1126/science.aam9321 · Cited by 3,844
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Research works printed but not linked: 3
- 47. Rousseau BA, Hou Z, Gramelspacher MJ, Zhang Y, Mol. Cell (2018), doi:10.1016/j.molcel. 2018.01.025. · doi:10.1016/j.molcel
- 63. Chen JS, Ma E, Harrington LB, Tian X, Doudna JA, bioRxiv, 226993 (2017).
- 71. Charlesworth CT et al., bioRxiv, 243345 (2018).
Cited by
Items 101–200 of 1,000
Citrus Genetic Engineering for Disease Resistance: Past, Present and Future
Sun, L., NASRULLAH, N., Ke, F., Nie, Z., Wang, P., & Xu, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215256 · Cited by 126
Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery
Noureddine, A., Maestas-Olguin, A., Saada, E. A., LaBauve, A. E., Agola, J. O., Baty, K. E., Howard, T. A., Sabo, J. K., Espinoza, C. R. S., Doudna, J. A., et al. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.07.027 · Cited by 116
Self-citationAdvancing pharmaceutical research: A comprehensive review of cutting-edge tools and technologies
Chen, J., Lin, A., & Luo, P. (2024) · Current Pharmaceutical Analysis · doi:10.1016/j.cpan.2024.11.001 · Cited by 112
Nucleic acid drug vectors for diagnosis and treatment of brain diseases
Lu, Z.-G., Shen, J., Yang, J., Wang, J.-W., Zhao, R.-C., Zhang, T.-L., Guo, J., & Zhang, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01298-z · Cited by 106
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research
You, L., Tong, R., Li, M., Liu, Y., Xue, J., & Lü, Y. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.02.008 · Cited by 128
“Fourth, CRISPR-Cas9 is valuable for nucleic acid-based imaging, detection, and diagnosis.(10) Finally, Figure 3 summarizes the applications of CRISPR-Cas9 technology in agriculture, material science, and various other fields.”
BackgroundMethodZhao, J., Song, Y., & Liu, D. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0705-x · Cited by 124
Hanewich-Hollatz, M. H., Chen, Z., Hochrein, L. M., Huang, J., & Pierce, N. A. (2019) · ACS Central Science · doi:10.1021/acscentsci.9b00340 · Cited by 114
Biocatalytic Metal–Organic Frameworks: Prospects Beyond Bioprotective Porous Matrices
Liang, J., & Liang, K. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202001648 · Cited by 117
Wu, Y., Luo, W., Weng, Z., Guo, Y., Yu, H., Zhao, R., Zhang, L., Zhao, J., Bai, D., Zhou, X., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac886 · Cited by 113
Cas12a Base Editors Induce Efficient and Specific Editing with Low DNA Damage Response
Wang, X., Ding, C., Yu, W., Wang, Y., He, S., Yang, B., Xiong, Y.-C., Wei, J., Li, J., Liang, J., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107723 · Cited by 109
“The CRISPR-Cas9 system has been successfully applied in various living organisms for genome editing (Hsu et al., 2014; Knott and Doudna, 2018; Komor et al., 2017).”
MethodThe Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases
Yang, X., Lu, D., Zhuo, J., Lin, Z., Yang, M., & Xu, X. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.46405 · Cited by 119
“Moreover, advanced approaches such as clustered regularly interspaced short palindromic repeat (CRISPR)-based technologies have revolutionized the genome editing field and have already been applied to the development of novel antimicrobial strategies [118, 119].”
BackgroundPramanik, D., Shelake, R. M., Kim, M. J., & Kim, J.-Y. (2021) · Molecular Plant · doi:10.1016/j.molp.2020.11.002 · Cited by 108
Yue, H., Huang, M., Tian, T., Xiong, E., & Zhou, X. (2021) · ACS Nano · doi:10.1021/acsnano.1c02372 · Cited by 111
Ma, L., Wang, J., Li, Y., Liao, D., Zhang, W., Han, X., & Man, S. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.130234 · Cited by 110
Improved genome editing by an engineered CRISPR-Cas12a
Ma, E., Chen, K., Shi, H., Stahl, E. C., Adler, B., Trinidad, M., Liu, J., Zhou, K., Ye, J., & Doudna, J. A. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac1192 · Cited by 110
“The decrease in editing level may stem from two possibilities: (1) protein dynamics are affected by mutation of W890A, resulting in a slower process in target search or trapping of the editor on the cut site which delays the process of recycling; or (2) reduced end-trimming activity on NTS after cis-cutting that could…”
BackgroundSelf-citationJo, C., Zhang, J., Tam, J. M., Church, G. M., Khalil, A. S., Segrè, D., & Tang, T. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100560 · Cited by 121
“4b) [131,132].”
Chen, S., Zhang, N., Zhou, G., Hussain, S., Ahmed, S., Tian, H., & Wang, S. (2021) · BMC Plant Biology · doi:10.1186/s12870-021-02907-9 · Cited by 109
Cas9 interrogates DNA in discrete steps modulated by mismatches and supercoiling
Ivanov, I. E., Wright, A. V., Cofsky, J. C., Aris, K., Doudna, J. A., & Bryant, Z. D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913445117 · Cited by 109
“The nuclease deficient version of the enzyme (dCas9), which can bind stably to targeted sites of the genome without introducing cuts, has also found broad applications in transcriptional regulation, epigenome engineering, and imaging (11, 12).”
BackgroundSelf-citationMullane, K., & Williams, M. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113945 · Cited by 105
Two HEPN domains dictate CRISPR RNA maturation and target cleavage in Cas13d
Zhang, B., Ye, Y., Ye, W., Perčulija, V., Jiang, H., Chen, Y., Li, Y., Chen, J., Lin, J., Wang, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10507-3 · Cited by 106
Mukai, H., Ogawa, K., Kato, N., & Kawakami, S. (2022) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2022.100450 · Cited by 117
“editing therapy is slowly becoming a reality [105,106].”
BackgroundBREEDIT: a multiplex genome editing strategy to improve complex quantitative traits in maize
Lorenzo, C. D., Debray, K., Herwegh, D., Develtere, W., Impens, L., Schaumont, D., Vandeputte, W., Aesaert, S., Coussens, G., de Boe, Y., et al. (2022) · The Plant Cell · doi:10.1093/plcell/koac243 · Cited by 115
Genome engineering via gene editing technologies in microalgae
Jeong, B., Jang, J.-H., & Jin, E. (2023) · Bioresource Technology · doi:10.1016/j.biortech.2023.128701 · Cited by 114
A glance at genome editing with CRISPR–Cas9 technology
Barman, A., Deb, B., & Chakraborty, S. (2019) · Current Genetics · doi:10.1007/s00294-019-01040-3 · Cited by 123
Hołubowicz, R., Du, S. W., Felgner, J. H., Šmidák, R., Choi, E. H., Palczewska, G., Menezes, C. R., Dong, Z., Gao, F., Medani, O., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01296-2 · Cited by 118
“The CRISPR/Cas9 system used in gene editing trials consists of a Cas9 nuclease that is targeted to a genomic site by a protospacer-adjacent motif (PAM) and guide RNA that focuses the binding of Cas9 on a 20-bp-long DNA protospacer 12 .”
Pixley, K. V., Falck‐Zepeda, J. B., Giller, K. E., Glenna, L., Gould, F. L., Mallory-Smith, C. A., Stelly, D. M., & Stewart, C. N. (2019) · Annual Review of Phytopathology · doi:10.1146/annurev-phyto-080417-045954 · Cited by 117
“Knott&Doudna (76) reviewed advances and prospects for usingCRISPR-Cas technologies for genetically engineering diverse genomes, including those of plants.”
BackgroundGenetic modulation of RAP alters fruit coloration in both wild and cultivated strawberry
Gao, Q., Luo, H., Li, Y., Liu, Z., & Kang, C. (2019) · Plant Biotechnology Journal · doi:10.1111/pbi.13317 · Cited by 113
“The clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein 9 (CRISPR/Cas9) technology has been widely used for genome editing in both animals and plants (Knott and Doudna, 2018).”
MethodZhao, X., Li, S., Liu, G., Wang, Z., Yang, Z., Zhang, Q., Liang, M., Liu, J., Li, Z., Tong, Y., et al. (2020) · 中国科学通报:英文版 · doi:10.1016/j.scib.2020.09.004 · Cited by 106
“One of the most well-known applications is genome editing, which relies on the ability of RNA-guided Cas proteins to target and cleave specific nucleic acid sequences [6,7].”
BackgroundMechanisms of powdery mildew resistance of wheat – a review of molecular breeding
Kang, Y., Zhou, M., Merry, A., & Barry, K. (2020) · Plant Pathology · doi:10.1111/ppa.13166 · Cited by 115
In Vivo T Cell-Targeting Nanoparticle Drug Delivery Systems: Considerations for Rational Design
Cevaal, P. M., Ali, A., Czuba‐Wojnilowicz, E., Symons, J., Lewin, S. R., Cortez‐Jugo, C., & Caruso, F. (2021) · ACS Nano · doi:10.1021/acsnano.0c09514 · Cited by 106
Li, H., Yang, J., Wu, G., Weng, Z., Song, Y., Zhang, Y., Vanegas, J. A., Avery, L., Gao, Z. J., Sun, H., et al. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202203826 · Cited by 116
Diwan, D., Rashid, M. M., & Vaishnav, A. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127180 · Cited by 111
Genetic glycoengineering in mammalian cells
Narimatsu, Y., Büll, C., Chen, Y., Wandall, H. H., Yang, Z., & Clausen, H. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100448 · Cited by 107
Acharya, S., Mishra, A., Paul, D., Ansari, A. H., Azhar, M., Kumar, M., Rauthan, R., Sharma, N., Aich, M., Sinha, D., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818461116 · Cited by 109
“3 proteins has emerged as a powerful technique in molecular biology with potentially far reaching applications in gene therapy (1-6).”
BackgroundWang, Q., Alariqi, M., Wang, F., Li, B., Ding, X. L., Rui, H., Li, Y., Xu, Z., Qin, L., Sun, L., et al. (2020) · Plant Biotechnology Journal · doi:10.1111/pbi.13417 · Cited by 105
“The diversity, modularity and efficacy of CRISPR-Cas systems have led to a biotechnological revolution (Jia and Wang, 2020; Knott and Doudna, 2018; Van Vu et al., 2020).”
BackgroundLiu, M.-S., Gong, S., Yu, H.-H., Jung, K., Johnson, K. A., & Taylor, D. W. (2020) · Nature Communications · doi:10.1038/s41467-020-17411-1 · Cited by 95
CRISPR screens in plants: approaches, guidelines, and future prospects
Gaillochet, C., Develtere, W., & Jacobs, T. B. (2021) · The Plant Cell · doi:10.1093/plcell/koab099 · Cited by 109
Zhang, Y., Guo, W., Chen, L., Shen, X., Yang, H., Fang, Y. V., Ouyang, W., Mai, S., Chen, H., Chen, S., et al. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.802716 · Cited by 116
“The CRISPR/Cas9-based genome-editing can help produce crop varieties, similar to non-transgenic crops, without adding any foreign DNA to the genome, and thus, has become a powerful tool to advance crop breeding (Knott and Jennifer, 2018; Chen et al., 2019; Schiemann et al., 2019; Gao, 2021).”
BackgroundLiu, P., Lin, Y., Zhuo, X., Zeng, J., Chen, B., Zou, Z., Liu, G., Xiong, E., & Yang, R. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202401486 · Cited by 102
RNA chemistry and therapeutics
Wang, S., Weissman, D., & Dong, Y. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01237-x · Cited by 116
All‐In‐One Dendrimer‐Based Lipid Nanoparticles Enable Precise HDR‐Mediated Gene Editing In Vivo
Farbiak, L., Cheng, Q., Wei, T., Álvarez‐Benedicto, E., Johnson, L. T., Lee, S. M., & Siegwart, D. J. (2021) · Advanced Materials · doi:10.1002/adma.202006619 · Cited by 108
The miniature CRISPR-Cas12m effector binds DNA to block transcription
Wu, W. Y., Mohanraju, P., Liao, C., Adiego-Pérez, B., Creutzburg, S. C. A., Makarova, K. S., Keessen, K., Lindeboom, T. A., Khan, T. S., Prinsen, S., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.11.003 · Cited by 103
Tissue-specific (ts)CRISPR as an efficient strategy for in vivo screening in Drosophila
Meltzer, H., Marom, E., Alyagor, I., Mayseless, O., Berkun, V., Segal-Gilboa, N., Unger, T., Luginbuhl, D. J., & Schuldiner, O. (2019) · Nature Communications · doi:10.1038/s41467-019-10140-0 · Cited by 106
CRISPR/Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBV
Ding, R., Long, J., Yuan, M., Zheng, X. Y., Shen, Y., Jin, Y., Yang, H., Li, H., Chen, S., & Duan, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094842 · Cited by 98
“In recent years, clustered regularly interspaced short palindromic repeats (CRISPR)associated (Cas), nuclease-based methods have provided a promising approach for rapidly adaptable, deployable detection [12,13].”
BackgroundDNA interference states of the hypercompact CRISPR–CasΦ effector
Pausch, P., Soczek, K. M., Herbst, D. A., Tsuchida, C. A., Al-Shayeb, B., Banfield, J. F., Nogales, E., & Doudna, J. A. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00632-3 · Cited by 107
Self-citationRUNX2-modifying enzymes: therapeutic targets for bone diseases
Kim, W., Shin, H.-L., Kim, B. S., Kim, H., & Ryoo, H. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0471-4 · Cited by 102
The ethics of genetic engineering and gene drives in conservation
Sandler, R. L. (2019) · Conservation Biology · doi:10.1111/cobi.13407 · Cited by 97
“The genetic analysis, synthesis, and editing techniques that underlie this possibility are developing quickly (Mei et al. 2016; Knott & Doudna 2018; Grunwald et al. 2019; IUCN 2019).”
MethodCRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells
Lin, P., Qin, S., Pu, Q., Wang, Z., Wu, Q., Gao, P., Schettler, J., Guo, K., Li, R., Li, G., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.03.033 · Cited by 93
“These systems have recently been developed into powerful, versatile tools for genome editing, agricultural engineering, and biotechnology (Knott and Doudna, 2018).”
BackgroundTransforming ecology and conservation biology through genome editing
Phelps, M. P., Seeb, L. W., & Seeb, J. E. (2020) · Conservation Biology · doi:10.1111/cobi.13292 · Cited by 92
Plant base editing and prime editing: The current status and future perspectives
Li, J., Zhang, C., He, Y., Li, S., Yan, L., Li, Y., Zhu, Z., & Xia, L. (2023) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13425 · Cited by 89
A CRISPR-based base-editing screen for the functional assessment of BRCA1 variants
Kweon, J., Jang, A.-H., Shin, H. R., See, J.-E., Lee, W., Lee, J. W., Chang, S., Kim, K., & Kim, Y. (2020) · Oncogene · doi:10.1038/s41388-019-0968-2 · Cited by 92
Molecular dynamics simulations of DNA–DNA and DNA–protein interactions
Yoo, J., Winogradoff, D. N., & Aksimentiev, A. (2020) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.06.007 · Cited by 93
Liu, F. X., Cui, J. Q., Park, H., Chan, K. W., Leung, T., Tang, B. Z., & Yao, S. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c00067 · Cited by 93
Si, X., Zhang, H., Wang, Y., Chen, K., & Gao, C. (2020) · Nature Protocols · doi:10.1038/s41596-019-0238-3 · Cited by 101
Chen, Y., Dolt, K. S., Kriek, M., BAKER, T. S., Downey, P. M., Drummond, N. J., Canham, M. A., Natalwala, A., Rosser, S. J., & Kunath, T. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14286 · Cited by 97
“Genome editing with CRISPR/Cas9 technology is being applied to address diverse medical problems, including cancer, HIV infection, and monogenic diseases (Hsu, Lander, & Zhang, 2014; Knott & Doudna, 2018).”
BackgroundWang, D., Li, F., Cao, S., & Zhang, K. (2020) · Theoretical and Applied Genetics · doi:10.1007/s00122-020-03557-5 · Cited by 90
Simon, A. J., d’Oelsnitz, S., & Ellington, A. D. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0157-4 · Cited by 96
CRISPR-Cas for Fungal Genome Editing: A New Tool for the Management of Plant Diseases
Vicente, I., Sarrocco, S., Malfatti, L., Baroncelli, R., & Vannacci, G. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00135 · Cited by 89
“The arrival of the CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats – CRISPR Associated protein 9) genome-editing technique enabled researchers to modify genomic sequences in a more precise way (Knott and Doudna, 2018).”
BackgroundMitigating tradeoffs in plant breeding
Dwivedi, S. L., Reynolds, M. P., & Ortiz, R. O. (2021) · iScience · doi:10.1016/j.isci.2021.102965 · Cited by 99
“Knocking down of AITR family genes in Arabidopsis by CRISPR/Cas9 genome editing system (Knott and Doudna, 2018) enhanced abiotic stress tolerance without fitness costs, for example, knocking down of AITR3 and AITR4 simultaneously in the aitr256 triple and aitr1256 quadruple mutants respectively,…”
BackgroundCRISPR/Cas13a‐Based MicroRNA Detection in Tumor‐Derived Extracellular Vesicles
Hong, J., Son, T., Castro, C. M., & Im, H. (2023) · Advanced Science · doi:10.1002/advs.202301766 · Cited by 100
Development and Application of Base Editors
Yang, B., Yang, L., & Chen, J. (2019) · The CRISPR Journal · doi:10.1089/crispr.2019.0001 · Cited by 85
Precise, predictable multi-nucleotide deletions in rice and wheat using APOBEC–Cas9
Wang, S., Zong, Y., Lin, Q., Zhang, H., Chai, Z., Zhang, D., Chen, K., Qiu, J., & Gao, C. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0566-4 · Cited by 89
Kang, Y., Su, G., Yu, Y., Cao, J., Wang, J., & Yan, B. (2022) · Environmental Science & Technology · doi:10.1021/acs.est.1c06733 · Cited by 88
Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing
Maule, G., Casini, A., Montagna, C., Ramalho, A. S., De Boeck, K., Debyser, Z., Carlon, M. S., Petris, G., & Cereseto, A. (2019) · Nature Communications · doi:10.1038/s41467-019-11454-9 · Cited by 86
Life in Deserts: The Genetic Basis of Mammalian Desert Adaptation
Rocha, J. L., Godinho, R., Brito, J. C., & Nielsen, R. (2021) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2021.03.007 · Cited by 98
“Gene editing for increased thermal tolerance or adaptive tolerance to dehydration/starvation and other genetic-rescue initiatives [81,82] may help accelerate adaptive capacity in arid regions, although such measures remain technically challenging and controversial.”
Recent Advances in CRISPR-Cas Technologies for Synthetic Biology
Jeong, S. H., Lee, H. J., & Lee, S. J. (2023) · The Journal of Microbiology · doi:10.1007/s12275-022-00005-5 · Cited by 94
“Genome editing mediated by the CRISPR-Cas system requires cleavage of two strands of a target DNA and recombination (Hsu et al., 2014; Knott & Doudna, 2018).”
BackgroundThe role of epigenetic mechanisms in the regulation of gene expression in the cyclical endometrium
Retis-Resendiz, A. M., González-García, I. N., León‐Juárez, M., Camacho‐Arroyo, I., Cerbón, M. A., & Vázquez-Martínez, E. R. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01103-8 · Cited by 92
“CRISPR-Cas9 could also be helpful in clarifying the importance of specific proteins necessary for embryo implantation that are downregulated in the endometrium of women with recurrent miscarriages [62, 63].”
BackgroundApplications of CRISPR-Cas9 as an Advanced Genome Editing System in Life Sciences
Tavakoli, K., Pour‐Aboughadareh, A., Kianersi, F., Poczai, P., Etminan, A., & Shooshtari, L. (2021) · BioTech · doi:10.3390/biotech10030014 · Cited by 94
Habimana, J. D. D., Huang, R., Muhoza, B., Kalisa, N. Y., Han, X. B., Deng, W., & Li, Z. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114033 · Cited by 94
CRISPR/Cas Systems‐Inspired Nano/Biosensors for Detecting Infectious Viruses and Pathogenic Bacteria
Zhang, X., Shi, Y., Chen, G., Wu, D., Wu, Y., & Li, G. (2022) · Small Methods · doi:10.1002/smtd.202200794 · Cited by 89
Disease mechanisms and gene therapy for Usher syndrome
Géléoc, G. S. G., & El-Amraoui, A. (2020) · Hearing Research · doi:10.1016/j.heares.2020.107932 · Cited by 84
Characterization of a thermostable Cas13 enzyme for one-pot detection of SARS-CoV-2
Mahas, A., Maršić, T., Masson, M. L.-P., Wang, Q., Aman, R., Zheng, C., Ali, Z., Alsanea, M. S., Al-Qahtani, A. A., Ghanem, B., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2118260119 · Cited by 86
“Since their discovery, type VI CRISPR Cas13 systems have provided efficient and versatile tools for RNA manipulation (7, 45).”
BackgroundLiu, P., Wen, S., Zhu, S., Hu, X., & Wang, Y. (2025) · Processes · doi:10.3390/pr13030916 · Cited by 96
Baerwald, M. R., Goodbla, A. M., Nagarajan, R. P., Gootenberg, J. S., Abudayyeh, O. O., Zhang, F., & Schreier, A. D. (2020) · Molecular Ecology Resources · doi:10.1111/1755-0998.13186 · Cited by 81
Enhancement of specialized metabolites using CRISPR/Cas gene editing technology in medicinal plants
Das, S., Kwon, M., & Kim, J. (2024) · Frontiers in Plant Science · doi:10.3389/fpls.2024.1279738 · Cited by 86
“…gene editing systems, namely, ZFN (Wright et al., 2004) and TALEN (Christian et al., 2010), because their fabrication requires complex protein engineering, high cost, and lack of versatility for building a multiplex mutation system (Knott and Doudna, 2018; Kim and Kim, 2019; Chen et al., 2019a).”
BackgroundCreating CRISPR-responsive smart materials for diagnostics and programmable cargo release
Gayet, R. V., de Puig, H., English, M. A., Soenksen, L. R., Nguyen, P. Q., Mao, A. S., Angenent-Mari, N. M., & Collins, J. J. (2020) · Nature Protocols · doi:10.1038/s41596-020-0367-8 · Cited by 83
Chen, W., Ma, J., Wu, Z., Wang, Z., Zhang, H., Fu, W., Pan, D., Jin, S. K., & Ji, Q. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.06.014 · Cited by 88
Evolution of plant mutagenesis tools: a shifting paradigm from random to targeted genome editing
Shelake, R. M., Pramanik, D., & Kim, J. (2019) · Plant Biotechnology Reports · doi:10.1007/s11816-019-00562-z · Cited by 83
Cutting back malaria: CRISPR/Cas9 genome editing of Plasmodium
Lee, M., Lindner, S. E., Lopez-Rubio, J.-J., & Llinás, M. (2019) · Briefings in Functional Genomics · doi:10.1093/bfgp/elz012 · Cited by 82
“Through evolution, prokaryotes have created a wide array of solutions to the same bacteriophage problem by inventing Cas proteins and guide RNAs of different compositions, structures and nucleic acid targets (reviewed in [8]).”
BackgroundA Saliva-Based RNA Extraction-Free Workflow Integrated With Cas13a for SARS-CoV-2 Detection
Azmi, I., Faizan, M. I., Kumar, R., Yadav, S. R., Chaudhary, N., Singh, D. K., Butola, R., Ganotra, A., Joshi, G. D., Jhingan, G. D., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.632646 · Cited by 80
“To circumvent these limitations, more robust methods based on CRISPR-Cas technology are employed, which utilizes collateral activities of Cas12 and Cas13 enzymes (Knott and Doudna, 2018; Li et al., 2019).”
MethodEfficient CRISPR/Cas9 genome editing in a salmonid fish cell line using a lentivirus delivery system
Gratacap, R. L., Regan, T. W., Dehler, C. E., Martín, S., Boudinot, P., Collet, B., & Houston, R. D. (2020) · BMC Biotechnology · doi:10.1186/s12896-020-00626-x · Cited by 80
Yan, T., Yang, K., Chen, C., Zhou, Z., Shen, P., Jia, Y., Yu, X. M., Zhang, Z., Shen, X., & Han, X. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121233 · Cited by 78
Natanzi, A. S., Poudineh, M., Karimi, E., Khaledi, A., & Kashani, H. H. (2025) · BMC Medicine · doi:10.1186/s12916-025-04323-4 · Cited by 88
“…drug release. pH-responsive pH-responsive nanoparticles, typically constructed from acid-labile linkers or pro-tonatable polymers (e.g., poly(histidine), poly(β-amino esters)), are designed to remain stable at physiological pH but undergo destabilization or payload release in acidic niches [113].”
A scoutRNA Is Required for Some Type V CRISPR-Cas Systems
Harrington, L. B., Ma, E., Chen, J. S., Witte, I. P., Gertz, D., Páez-Espino, D., Al-Shayeb, B., Kyrpides, N. C., Burstein, D., Banfield, J. F., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.06.022 · Cited by 76
Self-citationAdvanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma
Kong, H., Ju, E., Yi, K., Xu, W., Lao, Y., Cheng, D., Zhang, Q., Tao, Y., Li, M., & Ding, J. (2021) · Advanced Science · doi:10.1002/advs.202102051 · Cited by 85
Cas11 enables genome engineering in human cells with compact CRISPR-Cas3 systems
Tan, R., Krueger, R. K., Gramelspacher, M. J., Zhou, X., Xiao, Y., Ke, A., Hou, Z., & Zhang, Y. (2022) · Molecular Cell · doi:10.1016/j.molcel.2021.12.032 · Cited by 74
Liu, R., Yang, J., Yao, J., Zhao, Z., He, W., Su, N., Zhang, Z., Zhang, C., Zhang, Z., Cai, H., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01112-1 · Cited by 84
CRISPR/Cas systems for the detection of nucleic acid and non-nucleic acid targets
Su, W., Li, J., Chen, J., Chen, C., Wang, Y., Dai, H., Li, F., & Liu, P. (2023) · Nano Research · doi:10.1007/s12274-023-5567-4 · Cited by 86
Genetic reprogramming for NK cell cancer immunotherapy with CRISPR/Cas9
Afolabi, L. O., Adeshakin, A. O., Sani, M. M., Bi, J., & Wan, X. (2019) · Immunology · doi:10.1111/imm.13094 · Cited by 83
Novel Approaches for Sustainable Horticultural Crop Production: Advances and Prospects
Lastochkina, O. V., Aliniaeifard, S., Seifikalhor, M., Bosacchi, M., Maslennikova, D., & Lubyanova, A. R. (2022) · Horticulturae · doi:10.3390/horticulturae8100910 · Cited by 89
“In CRISPR systems, the targeting element is an RNA molecule of 17–20 nucleotides that complements the genomic target site [369].”
BackgroundFareh, M., Zhao, W. D., Hu, W., Casan, J. M. L., Kumar, A., Symons, J., Zerbato, J. M., Fong, D., Voskoboinik, I., Ekert, P. G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24577-9 · Cited by 82
Structural basis for target site selection in RNA-guided DNA transposition systems
Park, J.-U., Tsai, A. W.-L., Mehrotra, E., Petassi, M. T., Hsieh, S.-C., Ke, A., Peters, J. E., & Kellogg, E. H. (2021) · Science · doi:10.1126/science.abi8976 · Cited by 78
“The 32 RNA-guided DNA nuclease activity of CRISPR-Cas systems has been repurposed (most notably 33 in the case of CRISPR-Cas9) for programmable genomic editing by making precise double-strand 34 breaks in DNA (DSB) complementary to the RNA guide(1).”
MethodMicrobial Secondary Metabolites via Fermentation Approaches for Dietary Supplementation Formulations
Alexandru Vasile, R. U. S. U., Trif, M., & Rocha, J. M. (2023) · Molecules · doi:10.3390/molecules28166020 · Cited by 80
“This is especially true in light of the identification of DNA as a hereditary molecule and the potential for targeted genetic modification [55,56].”
BackgroundCas12a domain flexibility guides R-loop formation and forces RuvC resetting
Strohkendl, I., Saha, A., Moy, C., Nguyen, A.-H., Ahsan, M., Russell, R., Palermo, G., & Taylor, D. W. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.06.007 · Cited by 86
Pasin, F., Menzel, W., & Daròs, J. (2019) · Plant Biotechnology Journal · doi:10.1111/pbi.13084 · Cited by 80
“Complex traits could be engineered using virus populations and consortia as platforms for the delivery of sequence-specific editors and transcriptional modulators, genetic circuits or biosynthetic pathways (Kassaw et al., 2018; Knott and Doudna, 2018; Mahas et al., 2018; Murovec et al., 2017; Wurtzel and Kutchan, 2016…”
BackgroundFunctional metagenomics-guided discovery of potent Cas9 inhibitors in the human microbiome
Forsberg, K. J., Bhatt, I. V., Schmidtke, D. T., Javanmardi, K., Dillard, K. E., Stoddard, B. L., Finkelstein, I. J., Kaiser, B. K., & Malik, H. S. (2019) · eLife · doi:10.7554/elife.46540 · Cited by 74
“Using this functional selection, we find that many unrelated metagenomic clones from human oral and gut microbiomes protect against Streptococcus pyogenes Cas9 (SpyCas9), the variant used most commonly for gene editing applications ( Knott and Doudna, 2018 ).”
Therapeutic promise of engineered nonsense suppressor tRNAs
Porter, J. J., Heil, C. S., & Lueck, J. D. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1641 · Cited by 77
“Several nucleotide-based strategies including targeted pseudouridylation of PTCs in mRNA, CRISPR/Cas9 gene editing and nonsense suppressor tRNAs (sup-tRNAs) have been pursued as more specific methods to rescue PTC-containing gene function (Karijolich & Yu, 2014; Krishnamurthy et al., 2019; Lueck et al., 2019).”
BackgroundInfluentialA Duplex CRISPR-Cas9 Ribonucleoprotein Nanomedicine for Colorectal Cancer Gene Therapy
Wan, T., Pan, Q., Liu, C., Guo, J., Li, B., Yan, X., Cheng, Y., & Ping, Y. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c03708 · Cited by 73
CRISPR-based assays for rapid detection of SARS-CoV-2
Javalkote, V. S., Kancharla, N., Bhadra, B., Shukla, M. R., Soni, B., Sapre, A. V., Goodin, M. M., Bandyopadhyay, A., & Dasgupta, S. (2020) · Methods · doi:10.1016/j.ymeth.2020.10.003 · Cited by 73
“Cas9 enzyme is one of the ubiquitously used enzyme for genetic editing [31].”
Microbial Base Editing: A Powerful Emerging Technology for Microbial Genome Engineering
Wang, Y., Liu, Y., Zheng, P., Sun, J., & Wang, M. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.06.010 · Cited by 82
Metadata
- Authors
- Knott, G. J., & Doudna, J. A.
- Affiliations
- University of California, Berkeley (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Doudna, Jennifer A.
- Venue
- Science
- Published
- 2018-08-31
- Volume
- 361
- Issue
- 6405
- Pages
- 866-869
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6455913
- OpenAlex
- W2888908334
- Cited by
- 1,410
- References
- 76
- Citations by year
- 2026: 92 · 2025: 155 · 2024: 169 · 2023: 177 · 2022: 214 · 2021: 223 · 2020: 205 · 2019: 149 · 2018: 23
- FWCI
- 14.76
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR-Cas, genome editing, transcriptional regulation, CRISPR-Cas diagnostics, agricultural biotechnology
- MeSH terms
- Gene Editing, CRISPR-Associated Protein 9, RNA, Guide, CRISPR-Cas Systems, Animals, Bacterial Proteins, DNA, Endonucleases, Genetic Engineering, Humans, Plants, RNA, Transcription, Genetic, Molecular Imaging, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.